Latest interview, page-8

There are currently 86 Nasdaq biotech stocks trading below their cash value.
That is a record.
The sector is extremely unpopular.
Irrationally unpopular.
That will change...it always does.
Biotech is the future.
And Kazia will be a major part of that future.
Relax.
I do not want you guys to be suffering from ulcers when you get filthy rich.